Literature DB >> 110490

Pulmonary vasodilator activity of prostacyclin (PGI2) in the cat.

A L Hyman, P J Kadowitz.   

Abstract

We studied the pulmonary vascular effects of prostacylin, PGI2, in the cat with intact chest under conditions of controlled blood flow. Intralobar injections of PGI2, 0.03--1 microgram, decreased arterial pressure in the perfused lobe in a dose-dependent manner. Inasmuch as lobar blood flow was held constant and left artrial pressure was unchanged, the fall in lobar arterial pressure reflects a decrease in lobar vascular resistance. Prostaglandin E1 (PGE1) and nitroglycerin also decreased lobar arterial pressure; however, PGI2 had greater vasodilator activity than did these substances. Vasodilator responses to PGI2, PGE1, and nitroglycerin in absolute terms were dependent on the baseline level of tone in the pulmonary vascular bed. Prostacyclin reversed the hypertensive and platelet aggregating effects of ADP in the lobar vascular bed. These data indicate that PGI2 has significant vasodilator activity in the feline pulmonary lobar vascular bed.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 110490     DOI: 10.1161/01.res.45.3.404

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  17 in total

Review 1.  Targeting soluble guanylate cyclase for the treatment of pulmonary hypertension.

Authors:  George F Lasker; Jason H Maley; Edward A Pankey; Philip J Kadowitz
Journal:  Expert Rev Respir Med       Date:  2011-04       Impact factor: 3.772

2.  Effect of chronic sodium nitrite therapy on monocrotaline-induced pulmonary hypertension.

Authors:  Edward A Pankey; Adeleke M Badejo; David B Casey; George F Lasker; Russel A Riehl; Subramanyam N Murthy; Bobby D Nossaman; Philip J Kadowitz
Journal:  Nitric Oxide       Date:  2012-03-14       Impact factor: 4.427

3.  Pulmonary Arterial Hypertension-A Deadly Complication of Systemic Sclerosis.

Authors:  Edward A Pankey; Matthew Epps; Bobby D Nossaman; Albert L Hyman; Philip J Kadowitz
Journal:  J Clin Rheumatol Musculoskelet Med       Date:  2010-12-01

4.  Analysis of responses to the Rho-kinase inhibitor Y-27632 in the pulmonary and systemic vascular bed of the rat.

Authors:  David B Casey; Adeleke M Badejo; Jasdeep S Dhaliwal; James L Sikora; Alex Fokin; Neel H Golwala; Anthony J Greco; Subramanyam N Murthy; Bobby D Nossaman; Albert L Hyman; Philip J Kadowitz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-04-30       Impact factor: 4.733

Review 5.  Cellular and humoral mediators of pulmonary edema.

Authors:  A B Malik; W M Selig; K E Burhop
Journal:  Lung       Date:  1985       Impact factor: 2.584

6.  Amblyomma americanum tick saliva insulin-like growth factor binding protein-related protein 1 binds insulin but not insulin-like growth factors.

Authors:  Ž M Radulović; L M Porter; T K Kim; M Bakshi; A Mulenga
Journal:  Insect Mol Biol       Date:  2015-06-25       Impact factor: 3.585

Review 7.  Introduction: thromboxane in biological systems and the possible impact of its inhibition.

Authors:  M Verstraete
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

8.  Prostaglandins and thromboxane in the delayed phase of shock induced by Serratia marcescens endotoxin.

Authors:  J R Parratt; N Sharma; I J Zeitlin
Journal:  Br J Pharmacol       Date:  1984-05       Impact factor: 8.739

9.  Influence of prostaglandin synthesis inhibitors on pulmonary vasodilatory effects of hydralazine in dogs with hypoxic pulmonary vasoconstriction.

Authors:  L J Rubin; J D Lazar
Journal:  J Clin Invest       Date:  1981-01       Impact factor: 14.808

Review 10.  Lung Circulation.

Authors:  Karthik Suresh; Larissa A Shimoda
Journal:  Compr Physiol       Date:  2016-03-15       Impact factor: 9.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.